Skip to main content

Table 1 Unit costs estimated for the resource use categories

From: Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care

Resource use item

Unit cost

Reference

Moderate exacerbation

£87.39

NHS reference costs 2013-14; PSSRU 2014

Severe exacerbation

£1,486.99

NHS reference costs 2013-14

Hospital episode

£1,806.50

NHS reference costs 2013-14

GP visit at surgery

£46

PSSRU 2014

GP visit out of office

£91

Assumed to be same as home visits

GP visit admin

£28

PSSRU 2014

GP visit correspondence

£3

PSSRU 2014

GP visit practice nurse

£13

PSSRU 2014

GP visit home visit

£91

PSSRU 2014

SABD

£3.30

PCA 2014

Theophylline

£3.90

PCA 2014

LAMA

£38.72

PCA 2014

LABA

£35.81

PCA 2014

LABA+ICS

£48.64

PCA 2014

  1. GP, general practitioner; ICS, inhaled corticosteroid; LABA, long acting beta agonist; LAMA, long acting muscarinic antagonist; NHS, National Health Service; PCA, Prescription cost analysis; PSSRU, Personal Social Services Research Unit; SABD, Short acting bronchodilator